Genes, Exercise, Memory and Neurodegeneration



Status:Completed
Conditions:Alzheimer Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:60 - Any
Updated:3/1/2014
Start Date:October 2009
End Date:August 2011
Contact:Thomas O. Obisesan, MD, MPH
Email:Tobisesan@howard.edu
Phone:202-865-3776

Use our guide to learn which trials are right for you!

Effects of Standardized Aerobic Exercise-Training on Neurocognitive and Neurodegeneration

The primary purpose of this pilot study is to determine whether African Americans with mild
Alzheimer's disease (AD) can be enrolled and retained in a 6-month aerobic exercise-training
study.

This study will examine the effects of aerobic exercise-training on neurocognitive function,
and on cerebral glucose homeostasis. It is yet to be determined whether African Americans
with mild AD can be recruited into such a study, nor has the relationship of fitness
adaptation to neurocognitive function been systematically examined in this population. In
addition to the goal of assessing the intervention effects, the study will evaluate the
differential relationships of APOE to aerobic fitness-induced changes in neurocognition. The
long-term goal is to explore the mechanism by which fitness adaptation exerts an effect on
neurocognition, notably, low levels of high-density lipoprotein cholesterol (HDL-C),
elevated inflammation (C-reactive protein (CRP) and interleukins (IL-1A)), deranged glucose
homeostasis, hypertension and endothelia dysfunction are precursors of arteriolosclerosis,
decreased cerebral perfusion and oxygen deprivation, all of which may increase AD risk.
Because many of these putative AD risk factors are susceptible to lifestyle alterations, the
study will also assess their roles in aerobic fitness-related improvements in cognitive
function and reduction in AD risk.

Inclusion Criteria:

- Age over 60 years

- Ability to exercise vigorously without harm

- Mild AD

- Study partner

- In good general health

- Willing to exercise for 6 months

- Body Mass Index (BMI) less than 37

- Women participants must be postmenopausal for at least 2 years, and maintain current
hormone replacement therapy status and allowed medication usage for the duration of
the study

Exclusion Criteria:

- MMSE score below 20

- TG (Triglyceride) greater than 400 mg/dl

- LDL-C levels greater than 95% or HDL-C levels less than 10% of age and sex-adjusted
norms
We found this trial at
2
sites
Washington, District of Columbia 20060
?
mi
from
Washington,
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19140
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials